ProtoKinetix, Incorporated (PKTX) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Marietta, OH, 美国. 现任CEO为 Michael Richard Guzzetta.
PKTX 拥有 IPO日期为 2002-04-22, 在 Other OTC, 市值为 $2.74M.
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
